Cargando…
Antibiotics for COPD exacerbations: does drug or duration matter? A primary care database analysis
INTRODUCTION: Antibiotics are routinely given to people with chronic obstructive pulmonary disease (COPD) presenting with lower respiratory tract infection (LRTI) symptoms in primary care. Population prescribing habits and their consequences have not been well-described. METHODS: We conducted a retr...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797433/ https://www.ncbi.nlm.nih.gov/pubmed/31681477 http://dx.doi.org/10.1136/bmjresp-2019-000458 |
_version_ | 1783459826856099840 |
---|---|
author | Stolbrink, Marie Bonnett, Laura J Blakey, John D |
author_facet | Stolbrink, Marie Bonnett, Laura J Blakey, John D |
author_sort | Stolbrink, Marie |
collection | PubMed |
description | INTRODUCTION: Antibiotics are routinely given to people with chronic obstructive pulmonary disease (COPD) presenting with lower respiratory tract infection (LRTI) symptoms in primary care. Population prescribing habits and their consequences have not been well-described. METHODS: We conducted a retrospective analysis of antibiotic prescriptions for non-pneumonic exacerbations of COPD from 2010 to 2015 using the UK primary care Optimum Patient Care Research Database. As a proxy of initial treatment failure, second antibiotic prescriptions for LRTI or all indications within 14 days were the primary and secondary outcomes, respectively. We derived a model for repeat courses using univariable and multivariable logistic regression analysis. RESULTS: A total of 8.4% of the 9042 incident events received further antibiotics for LRTI, 15.5% further courses for any indication. Amoxicillin and doxycycline were the most common index and second-line drugs, respectively (58.7% and 28.7%), mostly given for 7 days. Index drugs other than amoxicillin, cardiovascular disease, pneumococcal vaccination and more primary care consultations were statistically significantly associated with repeat prescriptions for LRTI (p<0.05). The ORs and 95% CIs were: OR 1.28, 95% CI 1.10 to 1.49; OR 1.37, 95% CI 1.13 to 1.66; OR 1.33, 95% CI 1.14 to 1.55 and OR 1.05, 95% CI 1.02 to 1.07, respectively. Index duration, inhaled steroid use and exacerbation frequency were not statistically significant. The derived model had an area under the curve of 0.61, 95% CI 0.59 to 0.63. DISCUSSION: The prescription of multiple antibiotic courses for COPD exacerbations was relatively common—one in twelve patients receiving antibiotics for LRTI had a further course within 2 weeks. The findings support the current preference for amoxicillin as index drug within the limitations of this observational study. Further clinical trials to determine best practice in this common clinical situation appear required. |
format | Online Article Text |
id | pubmed-6797433 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-67974332019-11-01 Antibiotics for COPD exacerbations: does drug or duration matter? A primary care database analysis Stolbrink, Marie Bonnett, Laura J Blakey, John D BMJ Open Respir Res Chronic Obstructive Pulmonary Disease INTRODUCTION: Antibiotics are routinely given to people with chronic obstructive pulmonary disease (COPD) presenting with lower respiratory tract infection (LRTI) symptoms in primary care. Population prescribing habits and their consequences have not been well-described. METHODS: We conducted a retrospective analysis of antibiotic prescriptions for non-pneumonic exacerbations of COPD from 2010 to 2015 using the UK primary care Optimum Patient Care Research Database. As a proxy of initial treatment failure, second antibiotic prescriptions for LRTI or all indications within 14 days were the primary and secondary outcomes, respectively. We derived a model for repeat courses using univariable and multivariable logistic regression analysis. RESULTS: A total of 8.4% of the 9042 incident events received further antibiotics for LRTI, 15.5% further courses for any indication. Amoxicillin and doxycycline were the most common index and second-line drugs, respectively (58.7% and 28.7%), mostly given for 7 days. Index drugs other than amoxicillin, cardiovascular disease, pneumococcal vaccination and more primary care consultations were statistically significantly associated with repeat prescriptions for LRTI (p<0.05). The ORs and 95% CIs were: OR 1.28, 95% CI 1.10 to 1.49; OR 1.37, 95% CI 1.13 to 1.66; OR 1.33, 95% CI 1.14 to 1.55 and OR 1.05, 95% CI 1.02 to 1.07, respectively. Index duration, inhaled steroid use and exacerbation frequency were not statistically significant. The derived model had an area under the curve of 0.61, 95% CI 0.59 to 0.63. DISCUSSION: The prescription of multiple antibiotic courses for COPD exacerbations was relatively common—one in twelve patients receiving antibiotics for LRTI had a further course within 2 weeks. The findings support the current preference for amoxicillin as index drug within the limitations of this observational study. Further clinical trials to determine best practice in this common clinical situation appear required. BMJ Publishing Group 2019-09-17 /pmc/articles/PMC6797433/ /pubmed/31681477 http://dx.doi.org/10.1136/bmjresp-2019-000458 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Chronic Obstructive Pulmonary Disease Stolbrink, Marie Bonnett, Laura J Blakey, John D Antibiotics for COPD exacerbations: does drug or duration matter? A primary care database analysis |
title | Antibiotics for COPD exacerbations: does drug or duration matter? A primary care database analysis |
title_full | Antibiotics for COPD exacerbations: does drug or duration matter? A primary care database analysis |
title_fullStr | Antibiotics for COPD exacerbations: does drug or duration matter? A primary care database analysis |
title_full_unstemmed | Antibiotics for COPD exacerbations: does drug or duration matter? A primary care database analysis |
title_short | Antibiotics for COPD exacerbations: does drug or duration matter? A primary care database analysis |
title_sort | antibiotics for copd exacerbations: does drug or duration matter? a primary care database analysis |
topic | Chronic Obstructive Pulmonary Disease |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797433/ https://www.ncbi.nlm.nih.gov/pubmed/31681477 http://dx.doi.org/10.1136/bmjresp-2019-000458 |
work_keys_str_mv | AT stolbrinkmarie antibioticsforcopdexacerbationsdoesdrugordurationmatteraprimarycaredatabaseanalysis AT bonnettlauraj antibioticsforcopdexacerbationsdoesdrugordurationmatteraprimarycaredatabaseanalysis AT blakeyjohnd antibioticsforcopdexacerbationsdoesdrugordurationmatteraprimarycaredatabaseanalysis |